Similar Articles
941 Liver transplantation for hepatocellular carcinoma in Ireland: Pre-operative alpha-fetoprotein predicts tumour recurrence in a 14-year single-centre national experience
942 Proposal of new expanded selection criteria using total tumor size and 18F-fluorodeoxyglucose - positron emission tomography/computed tomography for living donor liver transplantation in patients with hepatocellular carcinoma: The National Cancer Center Korea criteria
943 Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients
944 Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma
945 Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatments
946 miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma
947 Application of cystoscope in surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus
948 Hepatocellular carcinoma after locoregional therapy: Magnetic resonance imaging findings in falsely negative exams
949 125I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma
950 Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA